GENOMMA LAB INTERNACIONAL SABGENOMMA LAB INTERNACIONAL SABGENOMMA LAB INTERNACIONAL SAB

GENOMMA LAB INTERNACIONAL SAB

No trades
See on Supercharts

Price target

26.000.000.00%
The 5 analysts offering 1 year price forecasts for LAB/B have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to LAB/B in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


LAB/B EPS for the last quarter is 0.66 MXN despite the estimation of 0.54 MXN. In the next quarter EPS is expected to reach 0.38 MXN. Track more of GENOMMA LAB INTERNACIONAL SAB financials and stay on top of what is up with the company.
In the next quarter GENOMMA LAB INTERNACIONAL SAB revenue is expected to reach ‪3.95 B‬ MXN. Check out GENOMMA LAB INTERNACIONAL SAB revenue and earnings and make informed decisions.
According to analysts, LAB/B price target is 26.00 MXN with a max estimate of 33.00 MXN and a min estimate of 18.00 MXN. Check if this forecast comes true in a year, meanwhile watch GENOMMA LAB INTERNACIONAL SAB stock price chart and keep track of the current situation with LAB/B news and stock market news.
We've gathered opinions of 5 analysts rating LAB/B stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.